Thus, SIRT1 may represent a biomarker of relapses and understanding the SIRT‐1 signaling and identifying immune‐mediated neuron deterioration can detect major therapeutic interventions that could prevent neuro complications in MS. The gene discussed is SIRT1; the disease is myeloid sarcoma.